| |
NewswireTODAY - /newswire/ -
Holmes Chapel, Cheshire, United Kingdom, 2010/06/24 - Thermo Fisher Scientific, Inc., the world leader in serving science, today announced its latest STP 420ES™ tissue processor for use in high-volume pathology laboratories (NYSE: TMO).
|
| |
The updated instrument features more robust hardware and ease-of-use, enabling the high-throughput processing of large volumes of tissue to meet the demands of today’s laboratories.
The Thermo Scientific STP 420ES models are designed to accommodate the most demanding requirements of researchers and pathologists in the field of tissue processing and have become an essential part of the laboratory workflow. The latest STP 420ES has been updated to include more robust hardware to handle the increasing number of samples processed in modern laboratories. The instrument’s dual chambers allow it to perform simultaneous or independent processing of up to 420 tissue cassettes, enabling higher throughput. In addition, ultimate fluid exchange is ensured by the innovative rotational movement of the main chamber. Rotational agitation is also up to seven-times more effective than conventional tidal agitation, eliminating the need for reprocessing.
The latest STP 420ES tissue processor can be combined with Fast Flex™ reagents to create a streamlined processing system, increasing throughput while maintaining tissue integrity. The Thermo Scientific Fast Flex tissue processing reagents combine the stability of traditional reagent technologies with the unique features of the STP 420ES to generate same-day-results. Additionally, Fast Flex reagents are easy to use, reducing labor burdens and drastically increasing fluid exchange, resulting in better processed tissue samples.
Further enhancements made to the STP 420ES include optimized user guiding software and touch screen operation. The STP 420ES is also supported by improved user documentation including user training manuals and quick reference guides to aid daily operation. With the introduction of its latest tissue processor, Thermo Fisher continues to offer excellent training to customers, ensuring instrument dependability.
Peter Brooks, the company’s international product manager for Anatomical Pathology in Europe, the Middle East and Asia Pacific, comments: “We are pleased to unveil the latest STP 420ES tissue processor, an easy-to-use instrument that features more robust software than previous models to enable increased throughput. The modern laboratory demands that tissue is processed efficiently and accurately in the shortest possible time and that instruments are user-friendly. The STP 420ES combines speed with ease-of-use and reinforces Thermo Fisher’s position as leading provider of instruments for high-quality tissue processing.”
Thermo Scientific is part of Thermo Fisher Scientific, Inc.
About Thermo Fisher Scientific
Thermo Fisher Scientific, Inc. (thermoscientific.com) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.
|
pathology[.]scottpr.com 
